Quality-of-life outcomes with pimitespib in patients with advanced gastrointestinal stromal tumor: results from the randomized, double-blind, placebo-controlled, phase III, CHAPTER-GIST-301 study. [PDF]
Komatsu Y +11 more
europepmc +1 more source
ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy-phase II investigator-initiated trial (NCCH2412/MK015). [PDF]
Fujii H +16 more
europepmc +1 more source
Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients [PDF]
Braga, Dario
core
The impact of the 2019 revision of China's drug administration law on the innovative output of pharmaceutical and biotechnology enterprises-a quasi-natural experimental study using sharp regression discontinuity design. [PDF]
Zhu Y, Liu Y, Chen Y, Meng L.
europepmc +1 more source
Correction: A cell-free SHED lysate-hydrogel system for oral ulcer healing with anti-inflammatory and pro-angiogenic effects. [PDF]
Dong N +13 more
europepmc +1 more source
Bio-inspired chemometric methods for simultaneous UV spectrophotometric determination of molnupiravir, nirmatrelvir, and favipiravir in pharmaceutical formulations and environmental samples. [PDF]
Abdelzaher AM, Al Kamaly O, Rahman MAA.
europepmc +1 more source
Chinese pharmacy students' knowledge, attitudes and practice about environmental risks of pharmaceuticals and their source control from the perspective of One Health. [PDF]
Ma S, Wang Y, Wang J.
europepmc +1 more source
Addition of Immune Checkpoint Inhibitor to Platinum Retreatment for Recurrent Non-Small Cell Lung Cancer After Perioperative Chemotherapy: A Multicenter Retrospective Study. [PDF]
Takakura T +6 more
europepmc +1 more source
A review of pharmaceutical removal from wastewater via hydrodynamic cavitation. [PDF]
Liu P, Gaudino EC, Lee J, Cravotto G.
europepmc +1 more source
Reconstructing the professional role of pharmacists in China from the perspective of public value theory: challenges and institutional pathways. [PDF]
Han K +5 more
europepmc +1 more source

